Image

Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China

Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China

Recruiting
65-80 years
All
Phase N/A

Powered by AI

Overview

Atrial fibrillation (AF) is a common arrhythmia in aging populations and is strongly associated with an increased risk of heart failure (HF) and adverse cardiovascular outcomes. However, early detection of HF among patients with AF remain inadequate in rural settings. This study aims to screen for HF among older adults with AF in rural China and to conduct long-term follow-up in order to observe the disease progression in patients with AF.

This study will recruit at least 2,500 elderly individuals aged between 65 and 80 years, with confirmed diagnoses of AF, residing in rural areas. Participants will undergo HF screening using NT-proBNP testing and echocardiographic assessment. Additionally, data will be collected on electrocardiographic signals, seismocardiography, voice, and demographic characteristics. Following data collection, participants will be followed up every three months to monitor the incidence and progression of HF as well as the occurrence of adverse cardiovascular events.

Eligibility

Inclusion Criteria:

  1. Permanent residents with local household registration in rural China.
  2. Aged 65-80 years.
  3. Electrocardiogram confirmation of AF or possession of a diagnostic certificate for AF issued by a specialist.
  4. Willing to participate in HF screening.
  5. Ability to understand the study procedures and provide written informed consent.

Exclusion Criteria:

  1. Expected life expectancy of less than 3 months.
  2. Severe renal insufficiency (Ccr \< 30ml/min) or ongoing dialysis treatment.
  3. Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.
  4. Indications for pacemaker implantation without having undergone implantation.
  5. Chronic obstructive pulmonary disease complicated by type II respiratory failure.
  6. Special populations, including patients with mental illnesses.

Study details
    Atrial Fibrillation (AF)
    Heart Failure
    Screening
    Progression

NCT07611084

Jiangsu Taizhou People's Hospital

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.